Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Our new book is a comprehensive look at a vital part of medicines development and regulatory affairs. Grab your copy today!
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
| 31 October 2013 | By Louise Zornoza •
China's Food and Drug Administration (CFDA) has issued comprehensive new rules governing the food and drug regulatory development process with a focus on public participation in that process and implementation of regulatory reform.
The new rules are wrapped in 59 chapters that cover every aspect of the regulatory process with a combination of new regulations and revision of existing rules.
The CFDA in its notice underscored the importance of broadening the channels of public participation and the public's right to know and the right to express "reasonable demands." Moreover, the agency noted the need to "clean the system" of regulations that do not meet economic and social development requirements.
CFDA: Regulatory Development Process Rules
Read all Breaking News from RegLink
Tags: regulation